Global Digital Genomes Market to Reach US$72.8 Billion by 2030
The global market for Digital Genomes estimated at US$33.7 Billion in the year 2024, is expected to reach US$72.8 Billion by 2030, growing at a CAGR of 13.7% over the analysis period 2024-2030. Sequencing & Analyzer Instruments, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$31.8 Billion by the end of the analysis period. Growth in the DNA / RNA Analysis Kits segment is estimated at 11.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$8.9 Billion While China is Forecast to Grow at 12.8% CAGR
The Digital Genomes market in the U.S. is estimated at US$8.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.2 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.
Global Digital Genomes Market - Key Trends & Drivers Summarized
Is Precision Health Entering the Age of the Digital Genome?
Digital genomes-virtual representations of an individual’s complete genetic code stored and analyzed using advanced computing systems-are transforming the landscape of personalized medicine, drug development, and disease prevention. The global market for digital genomes is being driven by the convergence of next-generation sequencing (NGS), AI-enabled bioinformatics, and cloud-based data storage, enabling rapid, scalable, and cost-effective genetic analysis.
A defining trend is the shift from siloed genetic testing to integrated digital genome platforms, which consolidate raw DNA data, phenotype linkage, health records, and real-time monitoring into unified interfaces. These platforms are finding increasing use in oncology, rare disease diagnostics, pharmacogenomics, and population genomics initiatives. Countries such as the U.S., U.K., and China are investing in national-scale genome mapping projects, boosting the adoption of data-rich, cloud-secure digital genome infrastructure.
How Are Technological Convergences Unlocking Genomic Potential?
AI and machine learning algorithms are central to the digital genome revolution, facilitating rapid variant detection, risk modeling, and therapeutic target identification. These technologies are helping clinicians interpret complex genomic datasets and match them with optimal treatments-ushering in an era of predictive and preventive medicine. Moreover, real-time updates to individual genome profiles via wearable-integrated health data are becoming possible, especially in longitudinal health studies.
Advancements in storage and encryption technologies are also making secure sharing of genetic data feasible. Federated data models and blockchain are being explored to allow decentralized access to genomic data without compromising patient privacy, a key concern in regulated environments like the EU under GDPR or the U.S. under HIPAA.
Where Is Demand Accelerating and Who Are the End-Users?
The digital genome market is expanding rapidly in North America and Europe, with Asia-Pacific emerging as a strategic growth frontier due to government-backed genome sequencing programs and expanding biotech ecosystems. End-users include academic research institutions, hospitals, biopharmaceutical companies, direct-to-consumer (DTC) genetic testing providers, and health insurers.
Population health initiatives-such as the UK's 100,000 Genomes Project or the NIH's All of Us research program-are key growth catalysts, while private genetic testing companies are deploying consumer-facing genome dashboards to connect genetic risk with lifestyle and wellness interventions.
What’s Driving Growth in the Digital Genomes Market?
The growth in the digital genomes market is driven by a confluence of genomic science, AI analytics, and demand for precision medicine. Rising affordability of whole genome sequencing, along with increased accessibility to cloud computing, is enabling more institutions to adopt digital genome platforms.
Healthcare systems are recognizing the value of genomics in risk stratification and early intervention, particularly in oncology, cardiology, and neurology. Pharmaceutical firms are using digital genome datasets to identify novel drug targets and stratify trial participants based on genetic responsiveness. Regulatory clarity and global collaborations on data sharing are further fueling the integration of digital genomes into mainstream medicine.
SCOPE OF STUDY:
The report analyzes the Digital Genomes market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Preparation Instruments); Application (Clinical, Forensics, Drug Discovery & Development, Other Applications); End-User (Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes, Other End-Users)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 44 Featured) -
10x Genomics
Agilent Technologies, Inc.
ArcherDx, Inc.
BGI Genomics
bioMerieux SA
Bio-Rad Laboratories, Inc.
Eurofins Scientific SE
Fabric Genomics, Inc.
Foundation Medicine, Inc.
Genewiz
Guardant Health, Inc.
Illumina, Inc.
Invitae Corporation
Myriad Genetics, Inc.
NanoString Technologies, Inc.
Oxford Nanopore Technologies Ltd.
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
QIAGEN N.V.
Thermo Fisher Scientific Inc.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.
We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.
As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.
To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!
APRIL 2025: NEGOTIATION PHASE
Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.
JULY 2025 FINAL TARIFF RESET
Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.
Reciprocal and Bilateral Trade & Tariff Impact Analyses:
USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.
Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.
COMPLIMENTARY PREVIEW
Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Digital Genomes - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Advances in Genomic Sequencing Technologies Propel Demand for Digital Genome Platforms
Rising Use of AI in Genomic Data Interpretation Accelerates Clinical Application of Digital Genomes
Personalized Medicine Trends Strengthen Business Case for Genome Digitization
Integration of Genomic Data with EHR Systems Enhances Predictive Healthcare Models
Growing Demand for Population-Wide Genomic Screening Expands Digital Genome Infrastructure Investment
Increased Focus on Rare Disease Diagnosis Drives Adoption of Comprehensive Genomic Databases
Data Privacy Regulations in Genomics Create Both Challenges and Opportunities for Secure Platform Development
Collaborations Between Biotech Firms and Cloud Providers Spur Innovation in Scalable Genome Data Storage
Pharma R&D Shifts Toward Genotype-Driven Drug Discovery Highlights Need for Digital Genome Platforms
Public Health Genomics Programs in Asia and Europe Generate Long-Term Growth Opportunities
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Digital Genomes Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Digital Genomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Digital Genomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Sequencing & Analyzer Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Sequencing & Analyzer Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for DNA / RNA Analysis Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for DNA / RNA Analysis Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Sequencing Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for Sequencing Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Sequencing & Analysis Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Sequencing & Analysis Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Sample Preparation Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Sample Preparation Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Diagnostic Centers & Forensic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 17: World 6-Year Perspective for Diagnostic Centers & Forensic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 19: World 6-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World 6-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 23: World 6-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 24: World Recent Past, Current & Future Analysis for Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 25: World 6-Year Perspective for Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World 6-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 29: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 30: USA Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 31: USA 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: USA 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 34: USA Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 35: USA 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
CANADA
TABLE 36: Canada Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 37: Canada 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: Canada 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 40: Canada Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 41: Canada 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
JAPAN
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 42: Japan Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 43: Japan 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 44: Japan Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Japan 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 46: Japan Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 47: Japan 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
CHINA
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 48: China Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 49: China 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 50: China Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: China 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 52: China Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 53: China 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
EUROPE
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 54: Europe Recent Past, Current & Future Analysis for Digital Genomes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 55: Europe 6-Year Perspective for Digital Genomes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Europe 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 58: Europe Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 59: Europe 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 60: Europe Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 61: Europe 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
FRANCE
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 62: France Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: France 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 64: France Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 65: France 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 66: France Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 67: France 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
GERMANY
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 68: Germany Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Germany 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 70: Germany Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 71: Germany 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 72: Germany Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 73: Germany 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
ITALY
TABLE 74: Italy Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: Italy 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 76: Italy Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 77: Italy 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 78: Italy Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 79: Italy 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
UNITED KINGDOM
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 80: UK Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: UK 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 82: UK Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 83: UK 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 84: UK Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 85: UK 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
REST OF EUROPE
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Rest of Europe 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 89: Rest of Europe 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 91: Rest of Europe 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
ASIA-PACIFIC
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Asia-Pacific 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 95: Asia-Pacific 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 97: Asia-Pacific 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
REST OF WORLD
TABLE 98: Rest of World Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Rest of World 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 100: Rest of World Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 101: Rest of World 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 102: Rest of World Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 103: Rest of World 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030